Our recent investigation revealed the presence and expansion of Tph in the peripheral blood and ST of early, ACPA+, treatment-naive RA (< 12 months of symptom onset and fulfilling the 2010 American College of Rheumatology/EULAR classification criteria) compared to the healthy blood and osteoarthritis ST respectively [31]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.